Avital Lev *, Roy Noy *, Kfir Oved *, Hila Novak *, Dina Segal *, Peter Walden ¹, Dietmar Zehn ¹, and Yoram Reiter *^{, @}

* Faculty of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel; and
¹ Department of Dermatology, Medical School Charite, Humboldt University, D-10117 Berlin, Germany

A.L. and R.N. contributed equally to this work.

^@ To whom correspondence should be addressed at: Department of Biology, Technion-Israel Institute of Technology, Technion City, Room 333, Haifa 32000, Israel.
Yoram Reiter, E-mail:    reiter@tx.technion.ac.il

A cancer immunotherapy strategy is described herein that combines the advantage of the well established tumor targeting capabilities of high-affinity recombinant fragments of Abs with the known efficient, specific, and potent killing ability of CD8 T lymphocytes directed against highly antigenic MHC-peptide complexes. Structurally, it consists of a previously uncharacterized class of recombinant chimerical molecules created by the genetic fusion of single-chain (sc) Fv Ab fragments, specific for tumor cell surface antigens, to monomeric scHLA-A2 complexes containing immunodominant tumor- or viral-specific peptides. The fusion protein can induce very efficiently tumor cell lysis, regardless of the expression of self peptide-MHC complexes. Moreover, these molecules exhibited very potent antitumor activity in vivo in nude mice bearing preestablished human tumor xenografts. These in vitro and in vivo results suggest that recombinant scFv-MHC-peptide fusion molecules could represent an approach to immunotherapy, bridging Ab and T lymphocyte attack on cancer cells.

1. Activated T-Lymphocyte Immunotherapy.

Further Topics in:  Euchromatin,  active DNA, and  RNA  ribo-regulators:

Links to Euchromatin Activator RNA Reviews:
Links to Euchromatin Activator RNA Research:
Links to Ultrastructural Probes of DNase I-Sensitive Sites:
Links to RNA as a Therapeutic Agent:
Links to Hodgkin Lymphoma Immuno-Pathology:
Links to Activated T-Lymphocyte Immunotherapy:
Links to Medical Systems Biology:

"Ultrastructural Probes of Active DNA Sites, and the RNA Activators of DNA".

For Further Information and Feedback:
E-mail: frenster@euchromatin.net